Covered recipient · General Payments record
JARED S WINOKER
Allopathic & Osteopathic Physicians Urology
General Payments · PY2021–2024
$24,599.37
- Reported across 69 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $9,769.95 | 4 |
| Food and Beverage | $1,221.68 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Ambu Inc. | $5,835.55 | 2 |
| Calyxo, Inc. | $2,150.06 | 6 |
| Ambu A/S | $1,600.00 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $1,291.93 | 8 |
| Novo Nordisk Health Care AG | $114.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Ambu A/S | $1,600.00 | 08/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1124769346 | CMS |
| Ambu Inc. | $15.60 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134078826 | CMS |
| Ambu Inc. | $5,819.95 | 04/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134076438 | CMS |
| Boston Scientific Corporation | $22.68 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092338837 | CMS |
| Boston Scientific Corporation | $15.58 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092338829 | CMS |
| Boston Scientific Corporation | $159.25 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092338841 | CMS |
| Boston Scientific Corporation | $18.84 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092338831 | CMS |
| Boston Scientific Corporation | $1,000.00 | 06/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1092338843 | CMS |
| Boston Scientific Corporation | $21.11 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092338833 | CMS |
| Boston Scientific Corporation | $32.64 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092338839 | CMS |
| Boston Scientific Corporation | $21.83 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092338835 | CMS |
| Calyxo, Inc. | $106.20 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099420576 | CMS |
| Calyxo, Inc. | $1,350.00 | 03/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1099420559 | CMS |
| Calyxo, Inc. | $181.91 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099420554 | CMS |
| Calyxo, Inc. | $207.28 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099420563 | CMS |
| Calyxo, Inc. | $178.85 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099420567 | CMS |
| Calyxo, Inc. | $125.82 | 12/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099420572 | CMS |
| Novo Nordisk Health Care AG | $114.09 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096553722 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.